Drug recall · June 7, 2017
Amoxicillin and Clavulanate Potassium Tablets recall
Why: Subpotent Drug; Clavulanic Acid
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Amoxicillin and Clavulanate Potassium Tablets, USP, 500 mg/125 mg, in 20 count bottles, Rx Only, Manufactured in Austria by Sandoz Gmbh for Sandoz Inc. Princeton NJ NDC 0781-1831-20
- Lots / codes
Lot FP8735, 8/2017
- Quantity
- 4,464 bottles
- Company
- Sandoz Inc, Princeton, NJ
- Distribution
- NY, OH
- Initiated
- April 26, 2017 · Voluntary: Firm initiated
- Classified
- May 26, 2017
- Reported
- June 7, 2017
- Ended
- August 19, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amoxicillin / clavulanate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.